CLINICAL_TRIALS ClinicalTrials.gov record update

Migraine Medication Effects on Urinary Symptoms

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06212661
Title field or adapter rule: {'original_value': 'Migraine Medication Effects on Urinary Symptoms', 'source_field': 'protocolSection.identificationModule.officialTitle'}
Ingested At: 2026-10-31T23:27:33.152281+00:00
Published At: 2026-10-19T00:00:00+00:00
Record Updated At: 2026-10-19
Source Retrieved At: 2026-10-31T22:18:36.041217+00:00
Timestamp Basis: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter
Date limitation: ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions: ["Overactive Bladder", "Bladder Pain Syndrome", "Migraine Disorders", "Overactive Bladder Syndrome", "Overactive Detrusor", "Migraine", "Interstitial Cystitis"]
protocolSection.statusModule.lastUpdatePostDateStruct: {"date": "2026-10-19", "type": "ACTUAL"}
protocolSection.identificationModule.nctId: "NCT06212661"
protocolSection.identificationModule.officialTitle: "Migraine Medication Effects on Urinary Symptoms"
protocolSection.statusModule.overallStatus: "ENROLLING_BY_INVITATION"
protocolSection.designModule.phases: null
protocolSection.statusModule.resultsFirstPostDateStruct: null

Study condition terms

Interventions recorded in this study

{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Ubrogepant (Ubrelvy™), oral, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Ubrogepant', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Rimegepant (Nurtec®), oral, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Rimegepant', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Atogepant (Qulipta™), oral, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Atogepant', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Eptinezumab (Vyepti®) injection, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Eptinezumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Fremanezumab (Ajovy®) injection, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Fremanezumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Galcanezumab (Emgality®) injection, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Galcanezumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['CGRP inhibitor'], 'description': 'Erenumab (Aimovig®) injection, dosage at discretion of clinical provider, for treatment of migraine headaches.', 'name': 'Erenumab', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])
{'armGroupLabels': ['BoNTA extracranial muscle injections'], 'description': 'Botolinum toxin A (Botox) injections into extracranial muscles, dosage at discretion of clinical provider, for treatment of migraines.', 'name': 'Botulinum toxin A', 'type': 'DRUG'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

Drug names recorded in this source

A recorded drug name is not by itself an indication or a condition-specific relationship.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.